Background Reproductive function in women with end stage renal disease generally
improves after kidney transplant. However, pregnancy remains challenging due to the risk of …

The long-term management of maintenance immunosuppression in kidney transplant
recipients remains complex. The vast majority of patients are treated with the calcineurin …

In kidney transplant recipients, cancer is one of the leading causes of death with a
functioning graft beyond the first year of kidney transplantation, and malignancies account …

Background Single-center trials and retrospective case series have reported promising
outcomes using kidneys from donors with hepatitis C virus (HCV) infection. However …

Background Antigen recognition of allo-peptides and HLA molecules leads to the activation
of donor-reactive T-cells following transplantation, potentially causing T-cell-mediated …

Background. Early detection of rejection in kidney transplant recipients holds the promise to
improve clinical outcomes. Development and implementation of more accurate, noninvasive …

To assess factors that influence the choice of induction regimen in contemporary kidney
transplantation, we examined center‐identified, national transplant registry data for 166 776 …

Currently trials of immunosuppression in transplantation are in decline because their
objectives remain focused on improving acute rejection rates and graft survival in the first 12 …

Esta guía de recomendaciones para el TR de donante vivo (TRDV) es un documento
elaborado con el patrocinio de la Sociedad Española de Nefrología, la Sociedad Española …

Background: Thymoglobulin (THG) and antithymocyte globulin-Fresenius (ATG-F) have not
been compared directly as induction therapies in kidney transplantation. Materials and …